Inhibition of hepatitis C viral RNA-dependent RNA polymerase by α-P-boranophosphate nucleotides: exploring a potential strategy for mechanism-based HCV drug design.
Inhibition of hepatitis C viral RNA-dependent RNA polymerase by α-P-boranophosphate nucleotides: exploring a potential strategy for mechanism-based HCV drug design.
复制标题
通过α-P-硼磷酸核苷酸抑制丙型肝炎病毒RNA依赖性RNA聚合酶:探索基于机制的HCV药物设计的潜在策略。
DOI:
10.1016/j.antiviral.2013.02.014
复制
发表时间:
2013-05
影响因子:
7.6
通讯作者:
Shaw, Barbara Ramsay
中科院分区:
文献类型:
--
作者:
Cheek, Marcus Adrian;Sharaf, Mariam L.;Dobrikov, Mikhail I.;Shaw, Barbara Ramsay
关键词:
Improved treatments for chronic HCV infections remain a challenge, and new chemical strategies are needed to expand the current paradigm. The HCV RNA polymerase (RdRP) has been a target for antiviral development. For the first time we show that the boranophosphate (BP) modification increases the substrate efficiency of ATP analogs into HCV NS5BΔ55 RdRP-catalyzed RNA. Boranophosphate nucleotides contain a borane (BH3) group substituted for a non-bridging phosphoryl oxygen of a normal phosphate group, resulting in a class of modified isoelectronic DNA and RNA mimics capable of modulating the reading and writing of genetic information. We determine that HCV NS5BΔ55, being a stereospecific enzyme, incorporates the Rp isomer of both ATPαB and the two boranophosphate analogs: 2’-O-methyladenosine 5’-(α-P-borano) triphosphate (2’-OMe ATPαB, 5a) and 3’-deoxyadenosine 5’-(α-P-borano) triphosphate (3’-dATPαB, 5b). The Rp diastereomer of ATPαB (6), having no ribose modifications, was found to be a slightly better substrate than natural ATP, showing a 42% decrease in the apparent Michaelis-Menten constant (Km). The IC50 of both 2’-O-Me and 3’-deoxy ATP was decreased with the boranophosphate modification up to 16-fold. This “borano effect” was further confirmed by determining the steady-state inhibitory constant (Ki), showing a comparable potency shift (21-fold). These experiments also indicate that the boranophosphate analogs 5a and 5b inhibit HCV NS5B through a competitive mode of inhibition. This evidence, together with previous crystal structure data, further supports the idea that HCV NS5B (in a similar manner to HIV-1 RT) discriminates against the 3’-deoxy modification via lost interactions between the 3’-OH on the ribose and the active site residues, or lost intramolecular hydrogen bonding interactions between the 3’-OH and the pyrophosphate leaving group during phosphoryl transfer. To our knowledge, these data represent the first time a phosphate modified NTP has been studied as a substrate for HCV NS5B RdRP.
登录
查看更多内容
影响因子:
13.5
作者:
Ghany, Marc G.;Nelson, David R.;Strader, Doris B.;Thomas, David L.;Seeff, Leonard B.
通讯作者:
Seeff, Leonard B.
影响因子:
5.4
作者:
Bressanelli, S;Tomei, L;De Francesco, R
通讯作者:
De Francesco, R
影响因子:
11.4
作者:
Meyer, P;Schneider, B;Canard, B
通讯作者:
Canard, B
DOI:
10.1074/jbc.m111.325530
发表时间:
2012-03-23
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Jin Z;Leveque V;Ma H;Johnson KA;Klumpp K
通讯作者:
Klumpp K
影响因子:
4.9
作者:
Carroll, Steven S.;Ludmerer, Steven;Olsen, David B.
通讯作者:
Olsen, David B.